SOPHiA GENETICS SA Files 6-K with Mid-Year Financials
Ticker: SOPH · Form: 6-K · Filed: 2024-08-06T00:00:00.000Z
Sentiment: neutral
Topics: financial-reporting, sec-filing, 6-K
TL;DR
SOPHIA GENETICS dropped mid-year financials, showing capital and reserves as of June 30, 2024.
AI Summary
SOPHiA GENETICS SA filed a 6-K report for the period ending June 30, 2024. The filing includes financial data for the first six months of 2024 and the second quarter of 2024, comparing it to the same periods in 2023. Key financial statement components like Issued Capital, Share Premium, Treasury Shares, Other Reserves, and Retained Earnings are detailed as of June 30, 2024, and December 31, 2023.
Why It Matters
This filing provides investors with an update on SOPHiA GENETICS SA's financial position and performance for the first half of 2024, allowing for assessment of trends and comparison against prior periods.
Risk Assessment
Risk Level: low — This filing is a routine financial disclosure (6-K) and does not contain significant new operational or strategic information that would immediately alter risk perception.
Key Numbers
- 2024-06-30 — Reporting Period End Date (Covers financial data for the first six months of 2024.)
- 2023-12-31 — Prior Year End Date (Provides comparative financial data from the end of the previous fiscal year.)
Key Players & Entities
- SOPHiA GENETICS SA (company) — Filer of the 6-K report
FAQ
What is the primary purpose of this 6-K filing?
The primary purpose is to report financial information for SOPHiA GENETICS SA for the period ending June 30, 2024, including comparative data from prior periods.
What specific financial components are detailed in the filing?
The filing details components such as Issued Capital, Share Premium, Treasury Shares, Other Reserves, and Retained Earnings.
What are the reporting periods covered by the financial data?
The financial data covers the six months ended June 30, 2024, and the three months ended June 30, 2024, with comparisons to the same periods in 2023.
What is the fiscal year-end for SOPHiA GENETICS SA?
The fiscal year-end for SOPHiA GENETICS SA is December 31.
Where is SOPHiA GENETICS SA headquartered?
SOPHiA GENETICS SA is headquartered in Rolle, Switzerland.
Filing Stats: 265 words · 1 min read · ~1 pages · Grade level 10.5 · Accepted 2024-08-06 07:08:15
Filing Documents
- soph-20240630.htm (6-K) — 96KB
- soph-20240630_d2.htm (EX-99.1) — 646KB
- sophiageneticssaex992q22024.htm (EX-99.2) — 297KB
- sophiageneticssaex993q22024.htm (EX-99.3) — 300KB
- 0001840706-24-000123.txt ( ) — 4542KB
- soph-20240630.xsd (EX-101.SCH) — 44KB
- soph-20240630_cal.xml (EX-101.CAL) — 57KB
- soph-20240630_def.xml (EX-101.DEF) — 118KB
- soph-20240630_lab.xml (EX-101.LAB) — 365KB
- soph-20240630_pre.xml (EX-101.PRE) — 245KB
- soph-20240630_htm.xml (XML) — 625KB
Management's discussion and analysis of financial condition and results of operations
Management's discussion and analysis of financial condition and results of operations 99.3 Press Release dated August 6 , 20 24